• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小鼠皮肤肿瘤促进的分子机制。

Molecular mechanisms of mouse skin tumor promotion.

机构信息

The University of Texas M. D. Anderson Cancer Center, Science Park - Research Division, P.O. Box 389, Smithville, TX 78957.

出版信息

Cancers (Basel). 2010;2(2):436-82. doi: 10.3390/cancers2020436.

DOI:10.3390/cancers2020436
PMID:21297902
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3033564/
Abstract

Multiple molecular mechanisms are involved in the promotion of skin carcinogenesis. Induction of sustained proliferation and epidermal hyperplasia by direct activation of mitotic signaling pathways or indirectly in response to chronic wounding and/or inflammation, or due to a block in terminal differentiation or resistance to apoptosis is necessary to allow clonal expansion of initiated cells with DNA mutations to form skin tumors. The mitotic pathways include activation of epidermal growth factor receptor and Ras/Raf/mitogen-activated protein kinase signaling. Chronic inflammation results in inflammatory cell secretion of growth factors and cytokines such as tumor necrosis factor-a and interleukins, as well as production of reactive oxygen species, all of which can stimulate proliferation. Persistent activation of these pathways leads to tumor promotion.

摘要

多种分子机制参与了皮肤癌的发生。通过直接激活有丝分裂信号通路或间接响应慢性创伤和/或炎症,或由于终端分化受阻或抗细胞凋亡,来诱导持续增殖和表皮增生,这对于启动细胞的克隆扩增是必要的,这些启动细胞带有 DNA 突变,从而形成皮肤肿瘤。有丝分裂途径包括表皮生长因子受体和 Ras/Raf/丝裂原活化蛋白激酶信号的激活。慢性炎症导致炎症细胞分泌生长因子和细胞因子,如肿瘤坏死因子-α和白细胞介素,以及产生活性氧物质,所有这些都可以刺激增殖。这些途径的持续激活导致肿瘤促进。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ce/3835086/1f7751209786/cancers-02-00436-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ce/3835086/a47004a5b234/cancers-02-00436-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ce/3835086/e7d252162106/cancers-02-00436-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ce/3835086/788d357808da/cancers-02-00436-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ce/3835086/1f7751209786/cancers-02-00436-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ce/3835086/a47004a5b234/cancers-02-00436-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ce/3835086/e7d252162106/cancers-02-00436-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ce/3835086/788d357808da/cancers-02-00436-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3ce/3835086/1f7751209786/cancers-02-00436-g004.jpg

相似文献

1
Molecular mechanisms of mouse skin tumor promotion.小鼠皮肤肿瘤促进的分子机制。
Cancers (Basel). 2010;2(2):436-82. doi: 10.3390/cancers2020436.
2
Role of the epidermal growth factor receptor and transforming growth factor alpha in mouse skin carcinogenesis.表皮生长因子受体和转化生长因子α在小鼠皮肤癌发生中的作用。
Prog Clin Biol Res. 1994;387:113-38.
3
Peracetylated (-)-epigallocatechin-3-gallate (AcEGCG) potently prevents skin carcinogenesis by suppressing the PKD1-dependent signaling pathway in CD34+ skin stem cells and skin tumors.乙酰化(-)-表没食子儿茶素-3-没食子酸酯(AcEGCG)通过抑制 CD34+皮肤干细胞和皮肤肿瘤中的 PKD1 依赖性信号通路,有效地预防皮肤癌发生。
Carcinogenesis. 2013 Jun;34(6):1315-22. doi: 10.1093/carcin/bgt042. Epub 2013 Feb 5.
4
Molecular mechanisms underlying the action of carcinogens in gastric cancer with a glimpse into targeted therapy.胃癌中致癌物作用的分子机制及靶向治疗一瞥
Cell Oncol (Dordr). 2022 Dec;45(6):1073-1117. doi: 10.1007/s13402-022-00715-3. Epub 2022 Sep 23.
5
Decoding cell death signals in liver inflammation.解析肝炎症中的细胞死亡信号。
J Hepatol. 2013 Sep;59(3):583-94. doi: 10.1016/j.jhep.2013.03.033. Epub 2013 Apr 6.
6
Multistage carcinogenesis in mouse skin.小鼠皮肤的多阶段致癌作用。
Pharmacol Ther. 1992;54(1):63-128. doi: 10.1016/0163-7258(92)90051-z.
7
Crucial role of phospholipase C epsilon in skin inflammation induced by tumor-promoting phorbol ester.磷脂酶Cε在促肿瘤佛波酯诱导的皮肤炎症中的关键作用。
Cancer Res. 2008 Jan 1;68(1):64-72. doi: 10.1158/0008-5472.CAN-07-3245.
8
Induction of ornithine decarboxylase activity is a necessary step for mitogen-activated protein kinase kinase-induced skin tumorigenesis.鸟氨酸脱羧酶活性的诱导是丝裂原活化蛋白激酶激酶诱导皮肤肿瘤发生的必要步骤。
Cancer Res. 2005 Jan 15;65(2):572-8.
9
Molecular and cellular basis for tumor promotion in mouse skin.小鼠皮肤肿瘤促进的分子和细胞基础。
Princess Takamatsu Symp. 1983;14:315-26.
10
A critical role for ras-mediated, epidermal growth factor receptor-dependent angiogenesis in mouse skin carcinogenesis.Ras介导的、表皮生长因子受体依赖性血管生成在小鼠皮肤癌发生中的关键作用。
Cancer Res. 2002 Jun 15;62(12):3402-7.

引用本文的文献

1
Costunolide inhibits the progression of TPA-induced cell transformation and DMBA/TPA-induced skin carcinogenesis by regulation of AKT-mediated signaling.木香烯内酯通过调节AKT介导的信号传导来抑制佛波酯(TPA)诱导的细胞转化以及7,12-二甲基苯并[a]蒽/佛波酯(DMBA/TPA)诱导的皮肤癌发生进程。
Cancer Cell Int. 2025 Mar 20;25(1):106. doi: 10.1186/s12935-025-03742-w.
2
Effect of narrowband ultraviolet B (311 nm) exposure on skin carcinogenesis in Wistar rats.窄谱中波紫外线(311纳米)照射对Wistar大鼠皮肤癌发生的影响。
J Adv Vet Anim Res. 2024 Dec 29;11(4):1105-1113. doi: 10.5455/javar.2024.k861. eCollection 2024 Dec.
3
Zinc oxide nanoparticles derived from Penicillium griseofulvum mitigate DMBA/TPA-promoted mice skin carcinogenesis by modulating NF-ĸB associated signalling.

本文引用的文献

1
Inducible cutaneous inflammation reveals a protumorigenic role for keratinocyte CXCR2 in skin carcinogenesis.可诱导的皮肤炎症揭示了角质形成细胞CXCR2在皮肤癌发生中的促肿瘤作用。
Cancer Res. 2009 Jan 1;69(1):319-28. doi: 10.1158/0008-5472.CAN-08-2490.
2
Multiple signaling pathways are responsible for prostaglandin E2-induced murine keratinocyte proliferation.多种信号通路参与前列腺素E2诱导的小鼠角质形成细胞增殖。
Mol Cancer Res. 2008 Jun;6(6):1003-16. doi: 10.1158/1541-7786.MCR-07-2144.
3
The tumour suppressor RASSF1A is a novel substrate of PKC.
源自灰黄青霉的氧化锌纳米颗粒通过调节NF-κB相关信号通路减轻DMBA/TPA诱导的小鼠皮肤癌发生。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan;398(1):891-902. doi: 10.1007/s00210-024-03311-4. Epub 2024 Jul 30.
4
TFCP2 as a therapeutic nexus: unveiling molecular signatures in cancer.TFCP2 作为治疗枢纽:揭示癌症中的分子特征。
Cancer Metastasis Rev. 2024 Sep;43(3):959-975. doi: 10.1007/s10555-024-10175-w. Epub 2024 Mar 7.
5
The phenomenon of phototoxicity and long-term risks of commonly prescribed and structurally diverse drugs.常用且结构多样药物的光毒性现象及长期风险。
J Photochem Photobiol. 2024 Feb;19. doi: 10.1016/j.jpap.2023.100221. Epub 2023 Dec 5.
6
NRF3 suppresses squamous carcinogenesis, involving the unfolded protein response regulator HSPA5.NRF3 抑制鳞状细胞癌变,涉及未折叠蛋白反应调节剂 HSPA5。
EMBO Mol Med. 2023 Nov 8;15(11):e17761. doi: 10.15252/emmm.202317761. Epub 2023 Oct 9.
7
Selective adhesion inhibition and hyaluronan envelope reduction of dermal tumor cells by cold plasma-activated medium.冷等离子体激活介质对皮肤肿瘤细胞的选择性黏附抑制和透明质酸囊泡减少。
Cell Adh Migr. 2023 Dec;17(1):1-19. doi: 10.1080/19336918.2023.2260642. Epub 2023 Sep 24.
8
Inhibition of the CoREST Repressor Complex Promotes Wound Re-Epithelialization through the Regulation of Keratinocyte Migration.抑制 CoREST 抑制复合物通过调节角质形成细胞迁移促进伤口再上皮化。
J Invest Dermatol. 2024 Feb;144(2):378-386.e2. doi: 10.1016/j.jid.2023.07.022. Epub 2023 Aug 25.
9
Natural Polymeric Nanobiocomposites for Anti-Cancer Drug Delivery Therapeutics: A Recent Update.用于抗癌药物递送治疗的天然高分子纳米生物复合材料:最新进展
Pharmaceutics. 2023 Jul 31;15(8):2064. doi: 10.3390/pharmaceutics15082064.
10
The potential preventive effect of dietary phytochemicals In Vivo.膳食植物化学物质在体内的潜在预防作用。
BDJ Open. 2023 Jul 18;9(1):30. doi: 10.1038/s41405-023-00157-5.
肿瘤抑制因子RASSF1A是蛋白激酶C的一种新型底物。
FEBS Lett. 2008 Jun 25;582(15):2270-6. doi: 10.1016/j.febslet.2008.05.028. Epub 2008 Jun 2.
4
Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17.转化生长因子β通过白细胞介素-17将免疫系统转变为直接促进肿瘤生长。
Cancer Res. 2008 May 15;68(10):3915-23. doi: 10.1158/0008-5472.CAN-08-0206.
5
Reduced susceptibility to two-stage skin carcinogenesis in mice with low circulating insulin-like growth factor I levels.循环胰岛素样生长因子I水平较低的小鼠对两阶段皮肤致癌作用的易感性降低。
Cancer Res. 2008 May 15;68(10):3680-8. doi: 10.1158/0008-5472.CAN-07-6271.
6
Mechanisms of ROS modulated cell survival during carcinogenesis.活性氧在致癌过程中调节细胞存活的机制。
Cancer Lett. 2008 Jul 18;266(1):30-6. doi: 10.1016/j.canlet.2008.02.029. Epub 2008 Mar 26.
7
Oxidative stress, DNA methylation and carcinogenesis.氧化应激、DNA甲基化与致癌作用。
Cancer Lett. 2008 Jul 18;266(1):6-11. doi: 10.1016/j.canlet.2008.02.026. Epub 2008 Mar 26.
8
Reactive species: a cell damaging rout assisting to chemical carcinogens.活性物质:一种协助化学致癌物的细胞损伤途径。
Cancer Lett. 2008 Jul 18;266(1):73-83. doi: 10.1016/j.canlet.2008.02.035. Epub 2008 Mar 25.
9
Tumor necrosis factor: renaissance as a cancer therapeutic?肿瘤坏死因子:作为一种癌症治疗手段会再度兴起吗?
Curr Cancer Drug Targets. 2008 Mar;8(2):124-31. doi: 10.2174/156800908783769346.
10
The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer.披着羊皮的狼:白细胞介素-6在免疫、炎症和癌症中的作用
Trends Mol Med. 2008 Mar;14(3):109-19. doi: 10.1016/j.molmed.2007.12.007. Epub 2008 Feb 7.